Two recent federal court decisions have changed the landscape of off-label prescription drug marketing by pharmaceutical companies. While providers may prescribe U.S. Food and Drug Administration (“FDA”)-approved drugs for off-label uses, pharmaceutical companies and their representatives are prohibited from promoting the use of FDA-approved drugs off-label as the Federal Drug and Cosmetic Act (“FDCA”) prohibits…Read More
The Changing Landscape of Off-Label Prescription Drug Marketing
Posted on July 16, 2013 in Health Law News
Published by: Hall Render